Since joining GSK , I am positively contributing to the expansionary efforts of the company with a continuous over-achievement of plan & Market Share Object.During this role I have been able to achieve & exceed the set targets, as well as :I am a member of the launched Urology team in GSK since 2016 responsible for GSK urology portfolio starting with relaunching Avodart then Launching Duodart in Egypt.We achieved great successful launch for Duodart in all aspectsBest Achiever in the entire DERMA Line in the perspective of Sales & Performance (2012,2013,2014)Awarded GSK GM award for ranking No.1 in sales and the highest market share of Dermovate & Cutivate.Double the Growth of GSK steroids (Dermovate-Betnovate-Cutivate)Achieving 120% in Launching Physiogel A.I.Launching All Stiefel (New GSK Dermatology Company in Egypt ) products (Physiogel-Driclor-Oilatum-Spectraban-Isotrex).Resposible for different portofolios (Allergy Team: Ceporex, Zyrtec,Bactroban, Flexonise) & (Derma: Physiogel, Spectraban, Oilatum, Driclor,Dermovate,Betnovate,Cutivate)Assigned to Lead Giza Team in perspective of coaching & sales. So,I am Eager to contribute in the growth of a progressive company where my educational background and skills in the pharmaceutical industry would be effectively utilized, challenged and developed.